Skip to content



Open Access

Can we cure ATL: new drugs and targeting ATL stem cells

  • Olivier Hermine1
Retrovirology201411(Suppl 1):O33

Published: 7 January 2014

No abstract submitted

Authors’ Affiliations

Department of adult hematology, laboratory of physiopathology and treatment of hematological disorders, Institut Imagine, University of Sorbonne Paris Cite, Necker Hospital, Paris, France


© Hermine; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.